Defects of cytochrome c oxidase in the substantia nigra of Parkinson's disease: An immunohistochemical and morphometric study

Movement Disorders

Volumn 12, Issue 1, 1997, Pages 9-16

  Itoh, Kyoko ^a   Weis, Serge ^a   Mehraein, Parviz ^a   Müller Höcker, Josef ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cytochrome c oxidase; Immunohistochemistry; Morphometry; Parkinson's disease; Substantia nigra

Indexed keywords

CYTOCHROME C OXIDASE;

AGED; AGING; ARTICLE; CELL DENSITY; CELL SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MORPHOMETRICS; NERVE CELL; NORMAL HUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY CHAIN; SUBSTANTIA NIGRA;

AGED; AGED, 80 AND OVER; BRAIN MAPPING; CELL AGING; ELECTRON TRANSPORT; ELECTRON TRANSPORT COMPLEX IV; FEMALE; HUMANS; LEWY BODIES; MALE; NEURONS; PARKINSON DISEASE; REFERENCE VALUES; SUBSTANTIA NIGRA;

EID: 0031028110     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870120104     Document Type: Article

References (11)

1. Jellinger K. Overview of morphological changes in Parkinson's disease. In: Yahr MD, Bergmann KJ, eds. Advances in neurology. New York: Raven Press, 1986:1-18.
2. Gibb WRG, Fearnley JM, Lees AJ. The anatomy and pigmentation of the human substantia nigra in relation to selective neuronal vulnerability. Adv Neural 1990;53:31-34.
3. Gibb WRG, Lees AJ. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J Neural Neurosurg Psychiatry 1991;54:388-396.
4. Fearnley JM, Lees AJ. Aging and Parkinson's disease: substantia nigra regional selectivity. Brain 1991;114:2283-2301.
5. Schapira AHV, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1989;1:1269.
6. Mizuno Y, Ohta S, Tanaka M, et al. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 1989;163:1450-1455.
7. Bindoff LA, Birch-Machin M, Carlidge NEF, Parker WD, Turnbull DM. Mitochondrial function in Parkinson's disease. Lancet 1989;1:49.
8. Parker WD, Boyson SJ, Parks JK. Abnormalities of electron transport chain in idiopathic Parkinson's disease. Ann Neural 1989;26:719-723.
9. Schapira AHV, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 1990;54:823-827.
10. Shoffner JM, Watts RL, Juncos JL, Torroni A, Wallace DC. Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann Neural 1991;30:332-339.
11. Hattori Y, Tanaka M, Ozawa T, Mizuno Y. Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease. Ann Neural 1991;30:563-571.